Results 191 to 200 of about 93,286 (337)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

open access: yesObesity, EarlyView.
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu   +13 more
wiley   +1 more source

Differential Proteomics of Large Extracellular Vesicles in Ovarian Cancer

open access: yesPROTEOMICS, EarlyView.
ABSTRACT Diverse extracellular vesicles (EVs) are present in all body fluids; however, knowledge of large EVs (lEVs) remains limited. Molecular EV profiles vary depending on EV size and the physiological circulatory system, even within the same patient. In this study, we aimed to characterize the proteomic profile of IEVs in ovarian cancer patients and
Kazuhiro Suzuki   +6 more
wiley   +1 more source

Human Papillomaviruses and Malignant Neoplasms of the Female Upper Reproductive Tract: A Comprehensive Review of the Literature. [PDF]

open access: yesCancers (Basel)
Karachalios C   +8 more
europepmc   +1 more source

Integration of the Comprehensive Physical Examination and Diagnostic Tools in Clinical Cardiology

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Regina Wilson   +3 more
wiley   +1 more source

A Model‐Based Meta‐Analysis of Pembrolizumab Effects on Patient‐Reported Quality of Life: Advancing Patient‐Centered Oncology Drug Development

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Pembrolizumab is an immune checkpoint inhibitor that has been approved for more than 20 different indications and has shown great survival benefits in various types of cancer. However, the reported benefits of pembrolizumab in patients' quality of life (QoL) have been inconsistent across different studies and different types of cancer.
Yiqin Zou   +4 more
wiley   +1 more source

Response to Integration of the Comprehensive Physical Examination and Diagnostic Tools in Clinical Cardiology

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yu‐Shien Kao   +2 more
wiley   +1 more source

Unraveling the Metabolic Influence of Olfactory Receptors in Cancer Cells

open access: yesSensory Neuroscience, EarlyView.
ORs are aberrantly expressed in various tumor types and regulate cancer cell metabolism through nonclassical signaling pathways, including PI3K/Akt, MAPK, and ERK. These receptors influence tumor proliferation, invasion, and immune evasion. Specific OR–ligand interactions offer promising opportunities for targeted cancer therapy and early diagnosis ...
Chengzhilin Li   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy